Pharma
Global Cancer/Tumor Profiling Market Opportunities and Forecast 2022-2029
  • DLR2370
  • 04 October, 2022
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Cancer/Tumor Profiling Market Opportunities and Forecast 2022-2029

Cancer/Tumor Profiling Market Overview:

In recent years, cancer treatment options have advanced significantly. From the initial surgical procedures to the most advanced next-generation technologies, we are now in a position to analyze and understand tumors on an individual basis, allowing us to provide individualized treatment options that may increase patient survival. In this review, we will look at how tumor profiling has changed over the years to provide more efficient and personalized treatment options, as well as how novel technologies can help us envision the future of precision oncology toward better management and, ultimately, increased survival.

According to a recent report by Emergen analysis, the Cancer/Tumor Profiling Market is anticipated to reach USD.ninety nine billion by then. The growth of this market is related to the increased use of biomarkers in melanoma profiling, which is followed by an increase in the use of proteomic techniques for biomarker analysis, helping to expand the biologic building system over the anticipated time period. The changing consumer preference for customised medications and the increase in melanoma incidents worldwide are driving the demand for the sector. According to the global health organisation WHO, Lung and Breast cancer is a common type of melanoma, with around. actor cases per year. The predicted length is driving the industry as cancer bump profiling's popularity begins to grow.

During the forecast period, the cancer tumour profiling market is expected to grow at a CAGR of 12.75%. This means that the market value, which was $9.35 billion in 2021, will skyrocket to $24.44 billion by 2029.

Report Includes

Report Metric  Details
Market size available for years 2022–2029
Base year considered 2021 (Accessible in 2019 - 2014)
Forecast period 2020–2027
CAGR ~12.75% CAGR(2022-2029)
Forecast unit Value (USD billion)
Segments covered Type of Cancer (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancer), Type of Biomarker (Genomic Biomarker, Protein Biomarker), Immunoassays, Next-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, In-Situ Hybridization, Microarrays, and Other Technologies (Genomics, Proteomics, Metabolomics, Epigenetics), Application (Research, Biomarker Discovery, Personalized Medicine, Clinical Application, Diagnostics, Prognostics, Screening, Treatment and Monitoring) (Research, Biomarker Discovery, Personalized Medicine, Clinical Application, Diagnostics, Prognostics, Screening, Treatment and Monitoring)
Regions covered North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
Companies covered Illumina, Inc. (US), QIAGEN N.V. (Germany), NeoGenomics Laboratories, Inc. (US), HTG Molecular Diagnostics, Inc. (US), Genomic Health Inc. (US), Caris Life Sciences (US), Helomics Corporation (US), NanoString Technologies, Inc. (US), Sysmex Corporation (Japan), Ribomed Biotechnologies, Inc. (US), Guardant Health, Inc. (US), Foundation Medicine (US) Roche Diagnostics (Switzerland), (US), GenScript Biotech Corporation (China), Tempus Labs (US), Boreal Genomics Inc (Canada), Perthera (US), Agendia (US), Omniseq(US), Histogene X (Belgium)


An overview of the global Cancer/Tumor Profiling market, and related technologies and developments. Analyses of global market trends, with historical data from 2018, 2019, and 2020 estimates and projections of CAGRs through 2029. It also includes breakdowns of the overall Cancer/Tumor Profiling market along with various segments, and by geographic region. Analysis of the stakeholder value chain in the Cancer/Tumor Profiling market and comprehensive profiles of leading companies in the industry

Report Scope

The report forecasts the size of the Cancer/Tumor Profiling market for components from 2020 through 2027
The Executive Summary provides a snapshot of key findings of the report. The introduction chapter includes research scope, market segmentation, research methodology, and definitions and assumptions. It involves extreme rigorous scientific methods, tools and techniques to estimate the market size. Exhaustive secondary research is being carried out to collect information related to the market, the parent market, and the peer market. Primary research is undertaken to validate the assumptions, findings, and sizing with the industry experts professionals across the value chain of the market. Both top-down and bottom-up approaches are employed to estimate the complete market size.

Cancer type, biomarker type, technology, technique, and application are the segments of the cancer tumour profiling market. The growth in these segments will assist you in analyzing meager growth segments in industries and providing users with a valuable market overview and market insights to assist them in selecting the primary market applications while making strategic decisions.

Cancer type

·        Colorectal Cancer

·        Prostate Cancer

·        Melanoma Cancer

·        Breast Cancer

·        Lung Cancer

·        Other Cancer

 

Biomarker type

 

·        Protein Biomarker

·        Genomic Biomarker

 

Technology

·        Genomics

·        Proteomics

·        Metabolomics

·        Epigenetics

 

Application

·        Research

·        Biomarker Discovery

·        Personalized Medicine

·        Clinical Application

·        Diagnostics

·        Prognostics

·        Screening

·        Treatment and Monitoring


Global Cancer/Tumor Profiling market Competitive Analysis:
Key players in the Global Cancer/Tumor Profiling market are Illumina, Inc. (US), QIAGEN N.V. (Germany), NeoGenomics Laboratories, Inc. (US), HTG Molecular Diagnostics, Inc. (US), Genomic Health Inc. (US), Caris Life Sciences (US), Helomics Corporation (US), NanoString Technologies, Inc. (US), Sysmex Corporation (Japan), Ribomed Biotechnologies, Inc. (US), Guardant Health, Inc. (US), Foundation Medicine (US) Roche Diagnostics (Switzerland), (US), GenScript Biotech Corporation (China), Tempus Labs (US), Boreal Genomics Inc (Canada), Perthera (US), Agendia (US), Omniseq(US), Histogene X (Belgium).

*All our reports are customizable as per customer requirements

This study forecasts revenue and volume growth at global, regional, and country levels from 2018 to 2029. The global Cancer/Tumor Profiling market is distributed on the basis of below-mentioned segments:

Global Cancer/Tumor Profiling market, By Types Segment:
Next-generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Microarray
Others


Global Cancer/Tumor Profiling market, By Application Segment :
Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Research Applications
Others

Global Cancer/Tumor Profiling market, By Region:
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa


Cancer/Tumor Profiling MARKET STUDY GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Cancer/Tumor Profiling Market Analysis (USD Billion), Insights and Forecast, 2016-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Segment 1
        • 5.2.1. Sub-Segment 1
        • 5.2.2. Sub-Segment 2
      • 5.3. Market Analysis, Insights and Forecast – By Segment 2
        • 5.3.1. Sub-Segment 1
        • 5.3.2. Sub-Segment 2
        • 5.3.3. Sub-Segment 3
        • 5.3.4. Others
      • 5.4. Market Analysis, Insights and Forecast – By Segment 3
        • 5.4.1. Sub-Segment 1
        • 5.4.2. Sub-Segment 2
        • 5.4.3. Sub-Segment 3
        • 5.4.4. Others
      • 5.5. Market Analysis, Insights and Forecast – By Region
        • 5.5.1. North America
        • 5.5.2. Latin America
        • 5.5.3. Europe
        • 5.5.4. Asia Pacific
        • 5.5.5. Middle East and Africa

      6. North America Cancer/Tumor Profiling Market Analysis (USD Billion), Insights and Forecast, 2016-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Segment 1
        • 6.2.1. Sub-Segment 1
        • 6.2.2. Sub-Segment 2
      • 6.3. Market Analysis, Insights and Forecast – By Segment 2
        • 6.3.1. Sub-Segment 1
        • 6.3.2. Sub-Segment 2
        • 6.3.3. Sub-Segment 3
        • 6.3.4. Others
      • 6.4. Market Analysis, Insights and Forecast – By Segment 3
        • 6.4.1. Sub-Segment 1
        • 6.4.2. Sub-Segment 2
        • 6.4.3. Sub-Segment 3
        • 6.4.4. Others
      • 6.5. Market Analysis, Insights and Forecast – By Country
        • 6.5.1. U.S.
        • 6.5.2. Canada

      7. Latin America Cancer/Tumor Profiling Market Analysis (USD Billion), Insights and Forecast, 2016-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Segment 1
        • 7.2.1. Sub-Segment 1
        • 7.2.2. Sub-Segment 2
      • 7.3. Market Analysis, Insights and Forecast – By Segment 2
        • 7.3.1. Sub-Segment 1
        • 7.3.2. Sub-Segment 2
        • 7.3.3. Sub-Segment 3
        • 7.3.4. Others
      • 7.4. Market Analysis, Insights and Forecast – By Segment 3
        • 7.4.1. Sub-Segment 1
        • 7.4.2. Sub-Segment 2
        • 7.4.3. Sub-Segment 3
        • 7.4.4. Others
      • 7.5. Insights and Forecast – By Country
        • 7.5.1. Brazil
        • 7.5.2. Mexico
        • 7.5.3. Rest of Latin America

      8. Europe Cancer/Tumor Profiling Market Analysis (USD Billion), Insights and Forecast, 2016-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Segment 1
        • 8.2.1. Sub-Segment 1
        • 8.2.2. Sub-Segment 2
      • 8.3. Market Analysis, Insights and Forecast – By Segment 2
        • 8.3.1. Sub-Segment 1
        • 8.3.2. Sub-Segment 2
        • 8.3.3. Sub-Segment 3
        • 8.3.4. Others
      • 8.4. Market Analysis, Insights and Forecast – By Segment 3
        • 8.4.1. Sub-Segment 1
        • 8.4.2. Sub-Segment 2
        • 8.4.3. Sub-Segment 3
        • 8.4.4. Others
      • 8.5. Market Analysis, Insights and Forecast – By Country
        • 8.5.1. UK
        • 8.5.2. Germany
        • 8.5.3. France
        • 8.5.4. Italy
        • 8.5.5. Spain
        • 8.5.6. Russia
        • 8.5.7. Rest of Europe

      9. Asia Pacific Cancer/Tumor Profiling Market Analysis (USD Billion), Insights and Forecast, 2016-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Segment 1
        • 9.2.1. Sub-Segment 1
        • 9.2.2. Sub-Segment 2
      • 9.3. Market Analysis, Insights and Forecast – By Segment 2
        • 9.3.1. Sub-Segment 1
        • 9.3.2. Sub-Segment 2
        • 9.3.3. Sub-Segment 3
        • 9.3.4. Others
      • 9.4. Market Analysis, Insights and Forecast – By Segment 3
        • 9.4.1. Sub-Segment 1
        • 9.4.2. Sub-Segment 2
        • 9.4.3. Sub-Segment 3
        • 9.4.4. Others
      • 9.5. Market Analysis, Insights and Forecast – By Country
        • 9.5.1. China
        • 9.5.2. India
        • 9.5.3. Japan
        • 9.5.4. Australia
        • 9.5.5. South East Asia
        • 9.5.6. Rest of Asia Pacific

      10. Middle East & Africa Cancer/Tumor Profiling Market Analysis (USD Billion), Insights and Forecast, 2016-2027

      • 10.1. Key Findings / Summary
      • 10.2. Market Analysis, Insights and Forecast – By Segment 1
        • 10.2.1. Sub-Segment 1
        • 10.2.2. Sub-Segment 2
      • 10.3. Market Analysis, Insights and Forecast – By Segment 2
        • 10.3.1. Sub-Segment 1
        • 10.3.2. Sub-Segment 2
        • 10.3.3. Sub-Segment 3
        • 10.3.4. Others
      • 10.4. Market Analysis, Insights and Forecast – By Segment 3
        • 10.4.1. Sub-Segment 1
        • 10.4.2. Sub-Segment 2
        • 10.4.3. Sub-Segment 3
        • 10.4.4. Others
      • 10.5. Market Analysis, Insights and Forecast – By Country
        • 10.5.1. GCC
        • 10.5.2. South Africa
        • 10.5.3. Rest of Middle East & Africa

      11. Competitive Analysis

      • 11.1. Company Market Share Analysis, 2018
      • 11.2. Key Industry Developments
      • 11.3. Company Profile
        • 11.3.1. Company 1
          • 11.3.1.1. Business Overview
          • 11.3.1.2. Segment 1 & Service Offering
          • 11.3.1.3. Overall Revenue
          • 11.3.1.4. Geographic Presence
          • 11.3.1.5. Recent Development
        *Similar details will be provided for the following companies
        • 11.3.2. Company 2
        • 11.3.3. Company 3
        • 11.3.4. Company 4
        • 11.3.5. Company 5
        • 11.3.6. Company 6
        • 11.3.7. Company 7
        • 11.3.8. Company 8
        • 11.3.9. Company 9
        • 11.3.10. Company 10
        • 11.3.11. Company 11
        • 11.3.12. Company 12
      List of Figures

      Figure 1: Global Cancer/Tumor Profiling Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
      Figure 2: Global Cancer/Tumor Profiling Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 3: Global Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 4: Global Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 5: Global Cancer/Tumor Profiling Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 6: Global Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 7: Global Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 8: Global Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 9: Global Cancer/Tumor Profiling Market Forecast (USD Billion), by Others, 2016-2027
      Figure 10: Global Cancer/Tumor Profiling Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 11: Global Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 12: Global Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 13: Global Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 14: Global Cancer/Tumor Profiling Market Forecast (USD Billion), by Others, 2016-2027
      Figure 15: Global Cancer/Tumor Profiling Market Value (USD Billion), by Region, 2019 & 2027
      Figure 16: North America Cancer/Tumor Profiling Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 17: North America Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 18: North America Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 19: North America Cancer/Tumor Profiling Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 20: North America Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 21: North America Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 22: North America Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 23: North America Cancer/Tumor Profiling Market Forecast (USD Billion), by Others, 2016-2027
      Figure 24: North America Cancer/Tumor Profiling Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 25: North America Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 26: North America Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 27: North America Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 28: North America Cancer/Tumor Profiling Market Forecast (USD Billion), by Others, 2016-2027
      Figure 29: North America Cancer/Tumor Profiling Market Forecast (USD Billion), by U.S., 2016-2027
      Figure 30: North America Cancer/Tumor Profiling Market Forecast (USD Billion), by Canada, 2016-2027
      Figure 31: Latin America Cancer/Tumor Profiling Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 32: Latin America Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 33: Latin America Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 34: Latin America Cancer/Tumor Profiling Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 35: Latin America Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 36: Latin America Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 37: Latin America Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 38: Latin America Cancer/Tumor Profiling Market Forecast (USD Billion), by Others, 2016-2027
      Figure 39: Latin America Cancer/Tumor Profiling Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 40: Latin America Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 41: Latin America Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 42: Latin America Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 43: Latin America Cancer/Tumor Profiling Market Forecast (USD Billion), by Others, 2016-2027
      Figure 44: Latin America Cancer/Tumor Profiling Market Forecast (USD Billion), by Brazil, 2016-2027
      Figure 45: Latin America Cancer/Tumor Profiling Market Forecast (USD Billion), by Mexico, 2016-2027
      Figure 46: Latin America Cancer/Tumor Profiling Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
      Figure 47: Europe Cancer/Tumor Profiling Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 48: Europe Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 49: Europe Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 50: Europe Cancer/Tumor Profiling Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 51: Europe Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 52: Europe Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 53: Europe Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 54: Europe Cancer/Tumor Profiling Market Forecast (USD Billion), by Others, 2016-2027
      Figure 55: Europe Cancer/Tumor Profiling Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 56: Europe Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 57: Europe Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 58: Europe Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 59: Europe Cancer/Tumor Profiling Market Forecast (USD Billion), by Others, 2016-2027
      Figure 60: Europe Cancer/Tumor Profiling Market Forecast (USD Billion), by U.K., 2016-2027
      Figure 61: Europe Cancer/Tumor Profiling Market Forecast (USD Billion), by Germany, 2016-2027
      Figure 62: Europe Cancer/Tumor Profiling Market Forecast (USD Billion), by France, 2016-2027
      Figure 63: Europe Cancer/Tumor Profiling Market Forecast (USD Billion), by Italy, 2016-2027
      Figure 64: Europe Cancer/Tumor Profiling Market Forecast (USD Billion), by Spain, 2016-2027
      Figure 65: Europe Cancer/Tumor Profiling Market Forecast (USD Billion), by Russia, 2016-2027
      Figure 66: Europe Cancer/Tumor Profiling Market Forecast (USD Billion), by Rest of Europe, 2016-2027
      Figure 67: Asia Pacific Cancer/Tumor Profiling Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 68: Asia Pacific Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 69: Asia Pacific Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 70: Asia Pacific Cancer/Tumor Profiling Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 71: Asia Pacific Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 72: Asia Pacific Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 73: Asia Pacific Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 74: Asia Pacific Cancer/Tumor Profiling Market Forecast (USD Billion), by Others, 2016-2027
      Figure 75: Asia Pacific Cancer/Tumor Profiling Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 76: Asia Pacific Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 77: Asia Pacific Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 78: Asia Pacific Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 79: Asia Pacific Cancer/Tumor Profiling Market Forecast (USD Billion), by Others, 2016-2027
      Figure 80: Asia Pacific Cancer/Tumor Profiling Market Forecast (USD Billion), by China, 2016-2027
      Figure 81: Asia Pacific Cancer/Tumor Profiling Market Forecast (USD Billion), by India, 2016-2027
      Figure 82: Asia Pacific Cancer/Tumor Profiling Market Forecast (USD Billion), by Japan, 2016-2027
      Figure 83: Asia Pacific Cancer/Tumor Profiling Market Forecast (USD Billion), by Australia, 2016-2027
      Figure 84: Asia Pacific Cancer/Tumor Profiling Market Forecast (USD Billion), by Southeast Asia, 2016-2027
      Figure 85: Asia Pacific Cancer/Tumor Profiling Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
      Figure 86: Middle East & Africa Cancer/Tumor Profiling Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 87: Middle East & Africa Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 88: Middle East & Africa Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 89: Middle East & Africa Cancer/Tumor Profiling Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 90: Middle East & Africa Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 91: Middle East & Africa Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 92: Middle East & Africa Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 93: Middle East & Africa Cancer/Tumor Profiling Market Forecast (USD Billion), by Others, 2016-2027
      Figure 94: Middle East & Africa Cancer/Tumor Profiling Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 95: Middle East & Africa Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 96: Middle East & Africa Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 97: Middle East & Africa Cancer/Tumor Profiling Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 98: Middle East & Africa Cancer/Tumor Profiling Market Forecast (USD Billion), by Others, 2016-2027
      Figure 99: Middle East & Africa Cancer/Tumor Profiling Market Forecast (USD Billion), by GCC, 2016-2027
      Figure 100: Middle East & Africa Cancer/Tumor Profiling Market Forecast (USD Billion), by South Africa, 2016-2027
      Figure 101: Middle East & Africa Cancer/Tumor Profiling Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027 
      List of Tables
      Table 1: Global Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 2: Global Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 3: Global Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 4: Global Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Region, 2016-2027
      Table 5: North America Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 6: North America Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 7: North America Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 8: North America Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 9: Europe Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 10: Europe Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 11: Europe Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 12: Europe Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 13: Latin America Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 14: Latin America Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 15: Latin America Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 16: Latin America Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 17: Asia Pacific Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 18: Asia Pacific Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 19: Asia Pacific Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 20: Asia Pacific Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 21: Middle East & Africa Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 22: Middle East & Africa Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 23: Middle East & Africa Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 24: Middle East & Africa Cancer/Tumor Profiling Market Revenue (USD Billion) Forecast, by Country, 2016-2027

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      [email protected]

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934